Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-163.17%Net Margin
VS
Market
Sector
Industry
History
$ 57.77Close
$ 7.36 - $ 60.55 52-Week Range
Ticker Information
Ticker
NKTRCompany Name
NEKTAR THERAPEUTICSSector
HealthcareIndustry
BiotechnologyExchange
NASDAQNEKTAR THERAPEUTICS - Net Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
NKTR - Net % Historical data
| Date | Net Income Common Stock | Net Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -122.27M | -163.17% | $ 74.93M |
| 3/31/2025 | $ -133.04M | -152.49% | $ 87.25M |
| 12/31/2024 | $ -118.96M | -120.86% | $ 98.43M |
| 9/30/2024 | $ -168.3M | -180.7% | $ 93.14M |
| 6/30/2024 | $ -177.08M | -190.09% | $ 93.16M |
| 3/31/2024 | $ -175.84M | -195.02% | $ 90.17M |
| 12/31/2023 | $ -276.06M | -306.31% | $ 90.12M |
| 9/30/2023 | $ -293.67M | -332.73% | $ 88.26M |
| 6/30/2023 | $ -306.88M | -349.75% | $ 87.74M |
| 3/31/2023 | $ -414.82M | -467% | $ 88.83M |
Key Performance Insights, Last 5 Years
- NEKTAR THERAPEUTICS's latest trailing twelve months (TTM) Net % stands at -269.83%.
- Over the past 5 years, NEKTAR THERAPEUTICS's average Net % has been -335.77%.
- The median Net % for NEKTAR THERAPEUTICS during this period was -336.52%
- NEKTAR THERAPEUTICS reached its highest Net % over the past 5 years at -120.86%.
- The lowest Net % recorded by NEKTAR THERAPEUTICS in the same timeframe -544.77%
NEKTAR THERAPEUTICS's Net % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net % Benchmarks
Similar metrics to Revenues:
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- EBITDA Margin - [Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
- Operating Margin - [Calculation] A company’s operating income [OpInc] as a percentage of [Revenue]. The operating margin measures how much profit a company produces for each dollar of revenue generated, after paying for variable costs such as wages and raw materials.
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
Definition of Net Margin
[Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.Net Inc. Cmn. / Revenues
(=) Net % Net % for NEKTAR THERAPEUTICS is calculated as follows: Net Inc. Cmn. [ $ -440.68M ] / Revenues [ $ 163.31M ]
(=) Net % [ -269.83% ] NKTR - Net Margin, Last 5 years
-544.77%
Minimum
Jun 30, 2022
-120.86%
Maximum
Dec 31, 2024
-335.77%
Average
-336.52%
Median
Net % Benchmark AnalysisMarket
The chart above depicts the distribution of Net % for companies in the Total Stock Market. The average Net % of the companies is 4.77% with a standard deviation of 19.84%.
The following table provides additional summary stats:
Net % in the Market:
| filtered constituents | 3.2K |
|---|---|
| min | -64.23% |
| max | 69.74% |
| average | 4.77% |
| median | 5.24% |
| std | 19.84% |